ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Bo Zhang
Matched on ORCID iD 0000-0002-2464-1422; OpenAlex author ID A5100335264. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.csbj.2024.04.021↗
- Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pancreatic cancer. Co-author DOI 10.1080/1061186x.2018.1452243↗
- Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2016.06.048↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qingcai Meng · 1 shared paper, 2024 · strength 0.20
- Rong Tang · 1 shared paper, 2024 · strength 0.20
- Jie Hua · 1 shared paper, 2024 · strength 0.20
- Jin Xu · 1 shared paper, 2024 · strength 0.20
- Wei J. Wang · 1 shared paper, 2024 · strength 0.20
- Chen Liang · 1 shared paper, 2024 · strength 0.20
- Qiong Du · 1 shared paper, 2024 · strength 0.20
- Yuan Liu · 1 shared paper, 2024 · strength 0.20
- Xianjun Yu · 1 shared paper, 2024 · strength 0.20
- Si Shi · 1 shared paper, 2024 · strength 0.20
- Xinguo Jiang · 2 shared papers, 2016–2018 · strength 0.14
- Paper Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pa… DOI 10.1080/1061186x.2018.1452243↗
- Paper Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancr… DOI 10.1016/j.biomaterials.2016.06.048↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.